Statements (44)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Skin
|
| gptkbp:age_group |
adults and children 6 years and older
|
| gptkbp:available_in |
over-the-counter
|
| gptkbp:brand |
gptkb:Afrin
|
| gptkbp:can_cause |
rebound congestion
|
| gptkbp:contraindication |
gptkb:diabetes
hypertension heart disease |
| gptkbp:dosage_form |
2 sprays in each nostril
|
| gptkbp:duration |
up to 12 hours
|
| gptkbp:first_introduced |
1990s
|
| gptkbp:flavor |
unflavored
|
| gptkbp:formulation |
spray
|
| https://www.w3.org/2000/01/rdf-schema#label |
Afrin No Drip
|
| gptkbp:ingredients |
oxymetazoline
|
| gptkbp:is_available_in |
various sizes
pump spray nasal mist |
| gptkbp:is_considered |
safe for short-term use
a decongestant a topical vasoconstrictor |
| gptkbp:is_known_for |
no drip formula
|
| gptkbp:is_often_used_in |
antihistamines
pain relievers other allergy medications |
| gptkbp:is_part_of |
OTC medications
Afrin product line |
| gptkbp:is_recommended_by |
gptkb:healthcare_professionals
|
| gptkbp:is_used_by |
people with allergies
people with colds people with sinusitis |
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:marketed_as |
non-drowsy
|
| gptkbp:packaging |
gptkb:bottle
|
| gptkbp:shelf_life |
3 years
|
| gptkbp:side_effect |
sneezing
nasal irritation dryness of the nasal mucosa |
| gptkbp:storage |
store at room temperature
|
| gptkbp:suitable_for |
long-term use
children under 6 years |
| gptkbp:used_for |
relief of nasal congestion
|
| gptkbp:bfsParent |
gptkb:Afrin
|
| gptkbp:bfsLayer |
6
|